MIST — Milestone Pharmaceuticals Inc · rev $797.0K

Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.

Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.

Use this MIST page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MIST quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MIST SEC filings page. Lician reads the product cache first so this HTML stays unique to Milestone Pharmaceuticals Inc even when a live quote feed is slow.

Milestone Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full MIST income, balance, and cash tables.

  • Revenue$0
  • Net Income-$63.1M
  • Total Assets$113.6M
  • Total Debt$0
  • Free Cash Flow-$49.3M

MIST recent filings